Provider of EARLY CANCER DETECTION TECHNOLOGY

www.earlycancerdetect.com

World Health Organization reported an estimated 386,300 new cases and 150,200 deaths from bladder cancer which occurred since 2008 worldwide and majority of it occurs in males. Bladder cancer is an uncontrolled abnormal growth and multiplication of cells in the urinary bladder which have broken free from the normal control mechanisms of the body. It has the ability to spread to other parts of the body including the lungs, bones, and liver. Urothelial carcinoma is the most common type which is usually associated with cigarette smoking having 50% incidence found in men and 30% in women. Adenocarcinoma of the bladder comprises about 2% and is associated with prolonged inflammation and irritation. And the third type is called Squamous cell carcinoma which comprises 1%-2% of bladder cancers and is associated with prolonged infection, inflammation, and irritation such as that associated with longstanding stones in the bladder.

According to research the longer and heavier the exposure to cigarette smoking, the greater the chance of developing bladder cancer. Most toxic chemicals in cigarette smoke are known carcinogens and travel in the bloodstream after being absorbed from the lungs and get filtered into the urine by the kidneys. It comes in contact with cells in the inner lining of the urinary system, including the bladder, and cause changes that develop into cancer cells. Men are more prone to developing cancer and at the highest risk due to a higher incidence of smoking and exposure to toxic chemicals with jobs including dye, rubber, aluminum, and leather workers, truck drivers, and pesticide applicators.

Painless hematuria (blood in the urine) that occurs in episodes Blood in the urine that has pain due to the blockage of urine by formation of blood clots; Patients may have the desire to urinate in small amounts and in short frequency, Inability to hold the urine for any length of time after the initial desire to void, or burning sensation while passing urine (dysuria); In advance stages, there may be bladder distention due to an obstruction of a tumor in the bladder neck. Flank pains may also be experienced due to obstruction of urine flow from the kidney to the bladder by a growing tumor mass in the bladder. Also, bone or joint pains, hemoptysis (coughing of blood) may be noted due to spread of cancer cells to the bones and/or lungs.

For a low-risk superficial bladder cancer, the chance of recurrence is about 15% in one year and 32% in five years after the initial diagnosis. For High-risk superficial tumors, multiple and large tumors are at increased risk for recurrence and progression. These tumors have a recurrence rate of 61%78% at one and five years respectively. They are also much likely to invade into the deeper layers with progression rates of 17%-45% at one and five years. Currently, bladder cancer is a topic of intense scientific research.

SAVING LIVES THROUGH EARLY CANCER DETECTION

made possible in the Philippines by PharmaCanada and PMILabs in partnership with St Dominic Medical Center.

People need not wait for symptoms to appear before they know that they already have cancer. This is non-invasive, very affordable, and informative screening test. A urine sample is needed in the assessment of precancerous conditions or cancerous changes in the urinary system.

Quantitative Pathology Systems

The ClearCyte system is an automated image cytometer that enables analysis of DNA content in slide-based cytology specimens. The system is very user friendly, easy to maintain and offers a high output capacity due to fully automated scanning process. ClearCyte is an in-vitro medical device with Health Canada and European CE Mark approvals. It has been designed under ISO and FDA development requirements.

Key Features

Precision measurements with precision DNA staining protocol Intelligent sorting capabilities excellent automated discrimination of isolated, measurable cell nuclei Walk-away automation (up to 50 slides per batch) High output (up to 2000 objects per minute) Interactive and flexible data review and reporting

If you would like to be tested for bladder cancer, contact Pharmacanada at numbers provided below.
TO ORDER OR FOR MORE INFORMATION : Call : (632) 553-4276, (632) 553-4205 Visit: PharmaCanada Inc. Penthouse 4, VGP Center, 6772 Ayala Ave., Makati City Phils. E-mail: info@pharmacanada.com.ph Website: www.earlycancerdetect.com
Test available at select medical and diagnostic centres. Visit http://earlycancerdetect.com/main/?page_id=646 for more information.

Early Cancer Detection (ECD) test

THANK YOU
Early Cancer Detection Provider